Literature DB >> 22675286

Subacute liver failure secondary to amyloid light-chain amyloidosis.

Theresa J Hydes1, Richard J Aspinall.   

Abstract

Entities:  

Year:  2012        PMID： 22675286      PMCID： PMC3365527     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  22 in total

Review 1.  The systemic amyloidoses.

Authors:  R H Falk; R L Comenzo; M Skinner
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

2.  Ascites in systemic amyloidosis.

Authors:  J A Gregg; T Herskovic; L G Bartholomew
Journal:  Arch Intern Med       Date:  1965-10

Review 3.  A practical update on the use of bortezomib in the management of multiple myeloma.

Authors:  Jesús San Miguel; Joan Bladé; Mario Boccadoro; Jamie Cavenagh; Axel Glasmacher; Sundar Jagannath; Sagar Lonial; Robert Z Orlowski; Pieter Sonneveld; Heinz Ludwig
Journal:  Oncologist       Date:  2006-01

Review 4.  Primary systemic amyloidosis--a diagnostic primer.

Authors:  M A Gertz; R A Kyle
Journal:  Mayo Clin Proc       Date:  1989-12       Impact factor: 7.616

5.  Obstructive jaundice caused by the deposition of amyloid-like substances in the extrahepatic and large intrahepatic bile ducts in a patient with multiple myeloma.

Authors:  T Terada; K Hirata; Y Hisada; Y Hoshii; Y Nakanuma
Journal:  Histopathology       Date:  1994-05       Impact factor: 5.087

6.  The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients.

Authors:  L B Lovat; M R Persey; S Madhoo; M B Pepys; P N Hawkins
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

7.  Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients.

Authors:  Miguel A Park; Paul S Mueller; Robert A Kyle; Dirk R Larson; Matthew F Plevak; Morie A Gertz
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

Review 8.  Primary amyloidosis and severe intrahepatic cholestatic jaundice.

Authors:  R A Peters; G Koukoulis; A Gimson; B Portmann; D Westaby; R Williams
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

Review 9.  Amyloidosis (AL). Clinical and laboratory features in 229 cases.

Authors:  R A Kyle; P R Greipp
Journal:  Mayo Clin Proc       Date:  1983-10       Impact factor: 7.616

10.  Hepatic amyloidosis (primary [AL], immunoglobulin light chain): the natural history in 80 patients.

Authors:  M A Gertz; R A Kyle
Journal:  Am J Med       Date:  1988-07       Impact factor: 4.965
View more
  3 in total

1.  Amyloidosis and subacute liver failure.

Authors:  Moby Joseph; Timothy J S Cross
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-03

2.  Acute liver failure due to primary amyloidosis in a nephrotic syndrome: a swiftly progressive course.

Authors:  Brigite Aguiar Cardoso; Rita Leal; Helena Sá; Mário Campos
Journal:  BMJ Case Rep       Date:  2016-03-10

3.  Multiple myeloma with hepatic amyloid light-chain amyloidosis manifesting as progressive liver failure.

Authors:  Monique Oye; Kimberly Sanders; Maged Ghali; Ahmad Alkhasawneh
Journal:  BMJ Case Rep       Date:  2020-06-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.